-2 -Antimicrobial properties of a long-chain, synthetic, cationic and hydrophobic amino acid block copolymer are reported. In 5 and 60 minute time-kill assays, solutions of K100L40 block copolymers (poly(L-lysine·hydrochloride)100-b-poly(L-leucine)40) at concentrations of 10 to 100 μg/mL show multi-log reductions in colony forming units of Gram-positive and Gram-negative bacteria, as well as yeast, including multidrug-resistant strains. Driven by association of hydrophobic segments, K100L40 copolymers form viscous solutions and self-supporting hydrogels in water at concentrations of 1 wt% and 2 wt%, respectively. These K100L40 preparations provide an effective barrier to microbial contamination of wounds, as measured by multi-log decreases of tissueassociated bacteria with deliberate inoculation of porcine skin explants, porcine open wounds, and rodent closed wounds with foreign body. Based on these findings, amino acid copolymers with the features of K100L40 can combine potent, direct antimicrobial activity and barrier properties in one biopolymer for a new approach to prevention of wound infections.
Introduction
Human skin is a specialized organ serving to divide outside from inside. [1] [2] [3] [4] One critical function is the protection of underlying tissues from microbial invasion. Skin performs this work by a combination of direct antimicrobial activities and microbial barrier properties. Disruption of our natural defenses by surgery, trauma, or disease, exposes deeper tissues to an array of microbial pathogens. This can set off a chain of events culminating in focal infection, and possible lifethreatening sepsis. [1, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Until wound closure, prevention relies on temporary replacement of antimicrobial activities and barrier properties. In current standard of care, the former is typically provided by systemic or local antimicrobials (antibiotics and antiseptics) and the latter by wound dressings and bandages. Incorporation of antimicrobial agents, such as silver, into hydrogels or other dressings delivers both functions in a single composition. [25, 26] Here, we report that both direct antimicrobial activities and microbial barrier properties can be designed into a single multifunctional biopolymer.
Cationic antimicrobials, both natural and man-made, have been widely studied and are active ingredients in a variety of healthcare products. While diverse in structure, cationic antimicrobials are unified by the display of one or more positive charges at physiologic pH that promote binding to multiple negatively charged structures on microbial surfaces. They include antiseptics, such as quaternary ammonium compounds; [28] [29] [30] [31] biguanides (e.g. chlorhexidine and polihexanide); [32] [33] [34] [35] a few antibiotics (e.g., polymyxins); [36] [37] [38] [39] [40] and most naturally occurring antimicrobial peptides (AMPs). [41] [42] [43] [44] [45] [46] [47] [48] Cationic antimicrobials are multimodal in mechanism(s) of action, binding multiple molecular targets and disrupting multiple cellular functions. They are sometimes called "membrane active agents" because they operate, at least in part, by disrupting -4 -the function and/or structure of microbial membranes. Typically, cationic antimicrobials display broad-spectrum effectiveness against both Gram-positive and Gram-negative bacteria.
A variety of synthetic polymers have been explored as antimicrobials, and reviews of advances have been published. [49] [50] [51] [52] For use of such polymers in medical settings, degradability in vivo is important. Recent progress has been made. For example, Hedrick and Yang have developed degradable antimicrobial micelles and hydrogels based on block copolymers containing carbonate linkages. [51, 53] Synthetic cationic polypeptides, especially those containing an abundance of Llysine residues, can display antimicrobial activity and are attractive for their degradability. [54, 55] Recently, this work has been expanded to include soluble statistical copolymers of lysine with various hydrophobic amino acids, [56] graft copolymers on other polymer or particle substrates, [57] [58] [59] and chemically cross-linked hydrogels. [60, 61] These studies point to the potential of using advanced synthetic biopolymers to combine antimicrobial activity with desirable chemical properties such as degradability. As the field progresses, additional studies will be required to better understand and optimize performance of antimicrobial biopolymers in vivo.
In a complementary area of research, Deming and colleagues have extensively studied long-chain, diblock amino acid copolymers (copolypeptides) containing discrete charged and hydrophobic segments. These diblock amino acid copolymers can be designed to form hydrogels with tunable physical properties, including stiffness and porosity. They also possess other characteristics that may be beneficial for healthcare applications, [62] [63] [64] [65] [66] [67] [68] [69] including degradability in vivo, [69] deformability and injectability, [62] and gel formation without the need for chemical crosslinking.
-5 -To address the urgent need for prevention of infections in the era of antibiotic resistance, we sought to develop amino acid block copolymers that would be broadly antimicrobial, and would fill and coat tissues to prevent microbial contamination of wounds. Preliminary studies demonstrated that diblock amino acid copolymers, containing cationic and hydrophobic blocks, could show substantial antimicrobial activity. [70] [71] [72] [73] A representative long-chain amino acid block copolymer of sequence poly(L-lysine·hydrochloride)100-b-poly(L-leucine)40 (K100L40; Figure 1 ) was selected for larger scale synthesis and more detailed evaluation of properties, both in vitro and in vivo.
Here, we report that K 100 L 40 copolymers demonstrate direct antimicrobial activity against a broad array of potential pathogens in vitro, and that these same copolymers, at higher concentrations, make viscous solutions and hydrogels that protect wounds from microbial contamination in vivo.
With this combination of advantageous properties, cationic and hydrophobic amino acid block copolymers, including K100L40, may offer a new approach for the prevention of infections in a variety of settings, including the wounds of surgery, trauma, and chronic disease.
Experimental Section

Synthesis and chemical analysis of K100L40 amino acid block copolymers.
K100L40 block copolymers were synthesized by contract manufacturer, Bachem, Inc. (Vista, CA).
The block copolymerization was accomplished by stepwise addition of monomers to benzyl amine initiator under high vacuum at a low temperature. [68] Nε-trifluoroacetyl-L-lysine N- Figure S2 ).
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Mechanical analyses of K100L40 amino acid block copolymers in aqueous media.
Samples were prepared by direct dissolution of K100L40 copolymers in sterile water (Sigma Aldrich W3500) at concentrations up to 30 mg/mL (3 wt%). After initial vortexing, samples were equilibrated at least 24 hours before additional vortexing and centrifugation (4,000 rpm, ~15 min)
to remove air bubbles.
Viscosity was assessed using calibrated Ubbelohde viscometers obtained from CANNONInstruments. The procedure was adapted from ASTM D 446-07. Samples of K100L40 were made at 0.5 and 1.0% w/w, and allowed to equilibrate at 37 °C for 30 min before being run. Each measurement was run in triplicate.
Hydrogel formation was assessed visually in a tilt tube assay. Hydrated K100L40 copolymer samples at various concentrations were added to 1 dram glass vials (Scientific Specialties B69302) and pulse centrifuged to collect and level material. Samples were inverted and images were taken within 4 seconds post-inversion. Further, sample resistance to probe penetration at a defined depth, or firmness, was assessed by texture analysis using a TA.XT2 Texture Analyzer (Texture Technologies Corp, Scarsdale, NY). [74, 75] In a typical experiment, a sample of K100L40 (~2 mL) was placed in a 5 mL polypropylene mailing tube (VWR 16465-262) at room temperature. A TA-57 7 mm diameter stainless steel cylinder probe was then lowered into the sample at 1 mm/sec.
The depth of the probe was normalized (depth = 0 mm) when the probe registered a positive force, and firmness was defined as the force at a given depth. Measurements were performed in triplicate.
Antimicrobial studies in vitro and ex vivo.
-8 - These assays were performed at iFyber (Ithaca, NY) using porcine skin obtained from a USDA approved facility with controlled herds. Porcine skin samples were cut into 10 mm diameter discs, artificially wounded with a 2 mm wide, 1.5 mm deep cavity using a Dremel tool, extensively washed, sterilized using chlorine gas, and washed. Explants were submersed in 1 wt% K100L40 in counts, and Pseudomonas Isolation Agar (PIA) for P. aeruginosa counts. At the conclusion of the study, animals were sedated (5 mg/kg Telazol) and euthanized (110 mg/kg pentobarbital sodium).
Rodent closed wound model with foreign body.
Sprague-Dawley male rats (300-400 g) were anesthetized and a 2 cm incision made on their back.
A blunt probe was used to create a small subcutaneous pocket into which a polypropylene mesh pre-soaked in K100L40 (1 wt% in water) or water was inserted. Immediately following insertion of pre-soaked mesh, 1 mL of K100L40 or water was applied directly into the wound pocket. Fifteen minutes later, wounds were inoculated with methicillin-resistant Staphylococcus aureus (MRSA; ATCC 33593) or P. aeruginosa (ATCC 27317) and the wound closed using Tissue Glue (3M) and staples. The treatment group consisted of 6 rats and the control group consisted of 8 rats. After 48 hours post-contamination, animals were euthanized and the bacterial burden in the implanted mesh and surrounding tissue was assessed.
Results & Discussion
K100L40 solutions demonstrate antimicrobial activity in time-kill assays in vitro.
K100L40 amino acid block copolymers were shown to be broadly antimicrobial against Grampositive and Gram-negative bacteria, as well as yeast. In time-kill assays with 60 minute exposures (Figure 2 ), K100L40 at 10 and 100 µg/mL in aqueous solutions caused multi-log reductions in CFU -11 -of Staphylococcus aureus and Pseudomonas aeruginosa. In a broader survey, K100L40 solutions were shown to be active against more than a dozen microbes, including several multidrug-resistant (MDR) strains and clinical isolates ( Table 1) . Notably, at a K100L40 concentration of 100 µg/mL, more than 4 log reduction in CFU was observed with Acinetobacter baumannii, MDR A.
baumannii, MDR P. aeruginosa, extended spectrum β-lactamase (ESBL) E. coli, Klebsiella pneumoniae, and K. pneumoniae that produce carbapenemase (KPC), all of which can cause clinical challenges. [78] Microbicidal activity was also demonstrated against the yeast C. albicans
and fluconazole-resistant C. albicans. In parallel studies, five minute exposures to 10 and 100 μg/mL of K 100 L 40 resulted in 1.8-2.7 log reduction in CFU of S. aureus (ATCC 6538; 2 experiments) and 4-6 log reduction in CFU of P. aeruginosa (ATCC 27853; 2 experiments).
K100L40 amino acid block copolymers readily form viscous solutions and selfsupporting hydrogels.
K100L40 copolymers in water demonstrated increased viscosity at concentrations of 0.5 wt% (5 mg/mL) and above and formed self-supporting hydrogels at concentrations of 2 wt% and above.
Using an Ubbelohde viscometer, K100L40 copolymers at concentrations of 0.5 and 1.0 wt% in water gave average values of 8.5 and 138.4 mm 2 /s at 37 °C, respectively; the reference value for water is 0.6959 mm 2 /s. [79] As depicted in Figure 3 , both the 2 wt% and 3 wt% preparations of K100L40 demonstrated gel formation, as assessed visually by lack of immediate flow in inverted samples.
Quantitative texture analysis on these samples confirmed the trends observed by viscometry and visual assessment of gel formation. These studies indicated increasing resistance to probe penetration from 0.5 wt% through 3.0 wt% (Figure 3c) . Overall, the formation of viscous solutions and hydrogels with K100L40 copolymers was found to be consistent with data on related block copolypeptides from the Deming lab, where physical associations of hydrophobic, -12 -entantiomerically pure poly(L-leucine) segments were found to drive formation of hydrated networks. [53] [54] [55] 3.3. K100L40 copolymers prepared as viscous solutions and hydrogels prevent microbial contamination of porcine skin explants.
We tested the ability of K100L40 copolymer preparations to block microbial contamination of tissues ex vivo in a porcine skin explant model. In this study, K100L40 samples prepared as viscous solutions (1 wt% in water) were applied to porcine explants 15 min prior to inoculation with P.
aeruginosa. Microbial burden was assessed in the skin explants three hours post-inoculation. As shown in Figure 4 , more than 10 5 CFU P. aeruginosa were found on explants pretreated with water, whereas no microbes were detected on explants pretreated with K100L40 preparations. The studies suggest that K100L40 copolymer preparations can provide a barrier against microbial contamination of tissues.
K100L40 copolymers prepared as viscous solutions and hydrogels prevent microbial contamination of wounds in vivo.
The ability of K100L40 copolymer preparations to prevent microbial contamination of wounds was assessed in two distinct animal models. In the first model, porcine open wounds were pretreated with K100L40 copolymer preparations and then inoculated with a mixture of S. epidermidis and P.
aeruginosa. As depicted in Figure 5 , a single application of K100L40 (2 wt% in water) fifteen minutes prior to microbial inoculation resulted in a 99.99% (4 log) reduction in CFU of S.
epidermidis (with no microbes detected) in tissue biopsies at 4 hours post-inoculation (N = 5 wounds/group; p<0.01) compared to water controls. Reduction of tissue associated P. aeruginosa was also observed with the 2 wt% preparation of K100L40 (p<0.01).
-13 -In the second model, rodent subcutaneous pockets with foreign body (mesh) were pretreated with K100L40 copolymer preparations. Fifteen minutes later, wounds were inoculated with methicillin resistant S. aureus (MRSA) and closed. After 48 hours, the microbial burdens of wound tissues and mesh were assessed. As depicted in Figure 6 , pretreatment with K100L40 preparations resulted in a 4-5 log reduction in CFU of MRSA versus control in both tissue and mesh. No microbes detected in wounds pretreated with K100L40 preparations. In a parallel study, multi-log reductions were also observed in tissue-associated and mesh-associated P. aeruginosa.
Effectiveness in these two animal models, one open wound over four hours and one closed wound over 48 hours, suggest that K100L40 copolymer preparations can help prevent microbial contamination of wounds in vivo. For potential clinical applications, it may be noteworthy that the formation of hydrogels with K100L40 copolymers is driven primarily by association of hydrophobic segments, which can be disrupted by application of shear stress. This property allows these block copolymer preparations to pass readily through small-bore openings of common delivery devices (e.g., syringes, needles, or catheters) and then reform hydrogels. [62, 65] Constructed from only two amino acids, these long-chain block copolymers are expected to show a favorable safety profile for local application to tissues. Beyond the scope of this paper, a series of preliminary safety studies in vivo have supported this expectation. Additional safety studies with K100L40 and related copolymers are underway. A combination of direct antimicrobial activity, barrier properties, and safety should enable deep tissue applications for the prevention of infections in surgery, trauma, and chronic wounds.
Conclusions -14 -
The studies presented here are based on the premise that when natural defenses are broken, the optimal approach combines direct antimicrobial activities and barrier properties. K100L40 copolymer preparations were evaluated in antimicrobial studies in vitro and in vivo and found to be broadly active against common wound pathogens. They demonstrated direct antimicrobial activity at low concentrations (i.e., 10 and 100 μg/mL in water) against both Gram-positive and
Gram-negative bacteria in vitro. Further, the design of K100L40 copolymers allowed for preparation and in vivo application of viscous solutions and self-supporting hydrogels (0.5 to 2 wt% in water).
At these higher concentrations, K 100 L 40 copolymer preparations were found to prevent microbial contamination of wounds. Potent, direct antimicrobial activity and barrier properties present a high hurdle for microbes to overcome.
In this era of antibiotic resistance, new approaches for the prevention of bacterial infections are needed. This is urgent, especially for life-threatening infections that can occur as a result of surgical procedures, trauma, or chronic disease. Today's antibiotics and antiseptics cannot fully address this challenge. [78, [80] [81] [82] Wounds disrupt skin's natural functions, and may become contaminated with a variety of microbes; it is increasingly likely that these will be multidrugresistant. Our goal is to replace both direct antimicrobial activities and barrier properties with a biocompatible material until wounds are closed by surgical procedure and/or natural healing processes. We believe that long-chain cationic and hydrophobic block copolypeptides, as exemplified here with K100L40, may achieve this goal. aeruginosa. Full-thickness wounds were pretreated with 1.0 mL of K100L40 or control (water) 15 minutes prior to inoculation with bacteria. Wounds were then biopsied for microbial counts after 4 hours. In both cases, the difference between control and 2% was significant at p<0.01. Data are presented as mean + SEM. *No microbes detected.
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